Font Size:
a
A
A
Keyword [Partitioned survival model]
Result: 1 - 2 | Page: 1 of 1
1.
Value Evaluation Of Pembrolizumab As A Single Agent In The First-line Treatment Of Advanced Non-small Cell Lung Cancer
2.
Pharmaco-economic Evaluation Of Sintilimab For First-line Treatment Of Advanced Non-small Cell Lung Cancer
<<First
<Prev Next>
Last>>
Jump to